A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery.
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Determine the optimal dose of IV N-acetylcysteine (NAC) to produce opioid reduction following
spine surgery and estimate the difference in opioid consumption between placebo and the
selected optimal dose.